Peptide drugs popular with influencers get backed by FDA panel, despite warnings from scientists

A federal health panel has narrowly recommended easing restrictions on several peptides favored by wellness influencers and celebrities, despite scientists' warnings about their lack of proven safety and efficacy. The panel advised the FDA to drop current bans on pharmacies producing injectable peptides like BPC-157 and TB-500. This move could significantly increase their availability, potentially leading to broader public use despite ongoing scientific debate. The decision underscores the tension between regulatory caution and the influence of social media trends on health decisions.